MARLBOROUGH — Detecting pancreatic cancer, which was the third leading cause of cancer deaths in 2021, according to the American Cancer Society, is difficult, involving things like CT scans or endoscopies — invasive at worst and inconvenient at best. Immunovia Inc., a diagnostic company, was recently approved to test a pancreatic cancer blood test on patients. “We have finally brought to market the first blood test dedicated to the early detection of cancer.”A blood sample is all that’s needed. Due to some state licensing differences, samples from 44 states will be heading to Marlborough for early cancer detection. “The early diagnosis of pancreatic cancer is key to improving patient outcomes and survival rates," said Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network, in a statement.

Source: MetroXpress August 25, 2021 09:00 UTC